Carvix Hits Public Markets in $1B SPAC Deal to Consolidate Auto Services

MIAMI, FL – March 31, 2026 – Carvix, Inc., a technology-focused automotive platform, is set to go public in a definitive merger agreement with special purpose acquisition company Crown Reserve Acquisition Corp. I (Nasdaq: CRAC). The deal assigns Carvix an implied enterprise value of $1.0 billion and paves the way for the combined company to trade on the Nasdaq Stock Market.

The transaction marks a significant bet that Carvix’s data-driven approach can successfully consolidate and modernize the vast, fragmented automotive services industry. Carvix, which focuses on acquiring, integrating, and scaling auto-related businesses, will become a wholly owned subsidiary of Crown Reserve, with its existing management team, led by Co-Founder and CEO Ramin Farahmand, continuing to lead operations post-merger.

“Carvix was built on the conviction that the automotive services industry is ready for a technology-led consolidator,” said Farahmand in the official announcement. “Access to the public markets through this combination with Crown Reserve gives us the capital and the profile to accelerate that strategy at scale.”

A Modern Engine for a Fragmented Industry

The core of Carvix’s investment thesis lies in the structure of the U.S. automotive repair market. Industry analysis confirms that the sector is highly fragmented, with the top five largest companies controlling only about 10-15% of the total market share. The landscape is dominated by tens of thousands of independent, family-owned shops and small regional chains.

Several powerful trends are creating an opportunity for a consolidator like Carvix. The average age of vehicles on U.S. roads continues to climb, surpassing 12 years and ensuring a steady demand for maintenance and repair. Simultaneously, cars are becoming exponentially more complex, packed with advanced driver-assistance systems (ADAS), sophisticated software, and electric powertrains. This technological shift requires significant capital investment in specialized tools and ongoing technician training, creating a high barrier for smaller operators to remain competitive.

Carvix proposes to solve this challenge with its “technology-enabled automotive platform.” The strategy involves using data analytics to identify acquisition targets, streamline the integration process, and optimize operations across its network of businesses. By implementing standardized processes, leveraging economies of scale for parts procurement, and enhancing the customer experience with digital tools, the company aims to improve margins and drive growth in a way that individual shops cannot.

The Financial Blueprint of the Deal

The transaction is structured as an all-stock deal, with the $1.0 billion valuation including a substantial performance-based component. Certain Carvix stockholders are eligible for up to 50 million additional shares over a four-year period, contingent upon the company hitting ambitious annual revenue and EBITDA targets starting in 2027. This earnout structure has become common in the more disciplined, post-boom SPAC market, aligning the interests of the target company with new public shareholders by tying a significant portion of the valuation to future performance rather than just projections.

To fund the combined company and ensure deal certainty, Crown Reserve will seek to raise a minimum of $80.0 million in a Private Investment in Public Equity (PIPE) financing and has secured a committed equity line of credit for at least $20.0 million. The deal is also subject to a minimum cash condition of $10.0 million at closing, a standard safeguard against high shareholder redemptions, which have been a persistent challenge for SPAC transactions.

Eric Sherb, Managing Member of Crown Acquisition Sponsor LLC, expressed confidence in the target. “We conducted an extensive search before selecting Carvix as our partner,” he stated. “The Company’s management team has built a differentiated platform with demonstrated unit economics in a large and underserved market. We are confident this combination will deliver long-term value for shareholders.”

Navigating a Competitive and Evolving Landscape

While Carvix’s model is compelling, it enters a competitive field where the consolidation playbook is already being run by several large, well-capitalized players. Publicly traded giants like Driven Brands Holdings Inc. (owner of Meineke, Maaco, and Take 5 Oil Change) and private equity-backed powerhouses like Caliber Collision and Crash Champions have been aggressively acquiring businesses for years, building massive networks across the collision and mechanical repair sectors.

Carvix’s ability to succeed will depend on whether its technology platform provides a true competitive advantage over these established consolidators, allowing it to integrate acquisitions more efficiently and operate them more profitably. The company's pivot to the public markets represents a strategic move to arm itself with the necessary capital to compete at this scale.

Interestingly, the merger with Carvix marks a significant pivot for Crown Reserve. The SPAC’s initial public offering documents from its formation had stated an intention to seek a target in the pharmaceutical, medical technology, or healthcare IT industries. The selection of an automotive company underscores the challenging environment for SPACs in finding suitable, ready-to-list partners, and the willingness of sponsors to look far beyond their initial target sectors to complete a deal.

The business combination, which is intended to be a tax-free reorganization, is subject to customary closing conditions, including approval from both Crown Reserve’s and Carvix’s shareholders and the effectiveness of a Form S-4 registration statement to be filed with the SEC. If all conditions are met, Carvix will soon find itself on the public stage, where its data-driven strategy for rolling up the corner auto shop will be put to the ultimate test.